The pharmaceutical landscape is witnessing a change with the emergence of GLP-1 transdermal systems . These cutting-edge formulations offer a potential alternative to providing glucagon-like peptide-1 https://miriamtqhc094352.techionblog.com/41182997/glp-1-patches-a-novel-way-to-treat-diabetes